X

Trial Profile

Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 29 Apr 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Immune globulin (Primary) ; Immune globulin (Primary)
Indications Allotransplant rejection; Ataxia; Chronic lymphocytic leukaemia; Guillain-Barre syndrome; Idiopathic thrombocytopenic purpura; Immunodeficiency disorders; Peripheral nervous system diseases
Focus Adverse reactions
Sponsors Baxalta; Shire; Takeda

Most Recent Events

28 May 2020 Status changed from active, no longer recruiting to completed.
23 Feb 2018 Status changed from recruiting to active, no longer recruiting.
15 Feb 2018 Planned End Date changed from 31 Jan 2020 to 30 Jun 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com